The Incidence and Nature of Adverse Events During Pediatric Sedation for MRI/CT in One Korean University Hospital: Retrospective Study
Trial Snapshot
- Phase
- Not Applicable
- Sponsor
- Yonsei University
- Enrollment
- 3,739
- Locations
- 1
- Primary Endpoint
- Frequency of Adverse Events
Study Overview
Brief Summary
Sedation and anesthesia for diagnostic imaging represents a rapidly growing field of practice, especially in children. Propofol is the most common sedative drug administered for MRI/CT. However, this drug is associated with adverse events, including pulmonary complications, and there has been no report on these complications in Korea.
The investigators reviewed 3739 charts of pediatric patients sedated for MRI/CT between January and November 2012.
In this study, the investigators will report the nature and frequency of adverse events associated with sedation for MRI/CT between January and November 2012.
Study Design
- Study Type
- Observational
- Time Perspective
- Retrospective
Eligibility Criteria
- Ages
- — to 18 Years (Child, Adult)
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •Requiring sedation for MRI/CT, aged 0- 18 years
Exclusion Criteria
- Not provided
Arms & Interventions
sedation group
Children requiring sedation for MRI/CT
Intervention: pediatric sedation (propofol, ketamine, etc) (Drug)
Outcomes
Primary Outcomes
Frequency of Adverse Events
Time Frame: 24 hours
The investigators will review all adverse events that are associated with pediatric sedation for MRI/CT
Secondary Outcomes
No secondary outcomes reported